Alnylam Pharmaceuticals, Inc.ALNYNASDAQ
Loading
EPS Growth AcceleratingAccelerating
Percentile Rank100
5Y CAGR+92.1%
Year-over-Year Change
Year-over-year earnings per share growth rate
5Y CAGR
+92.1%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
26.2x
Strong expansion
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 209.63% |
| 2024 | 38.07% |
| 2023 | 62.15% |
| 2022 | -29.17% |
| 2021 | 3.49% |
| 2020 | 8.01% |
| 2019 | -7.13% |
| 2018 | -39.67% |
| 2017 | -13.15% |
| 2016 | -38.84% |